Jone Salvador-Moya

Jone Salvador-Moya

Auto-generated profile, based on publicly available information

Jone Salvador-Moya

Department of Cell Biology and Histology, Faculty of Medicine and Nursing, University of the Basque Country (EHU), 48940 Leioa, Bizkaia, Spain

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 October 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
BRBeatriz Pardo Rodriguez
Beatriz Pardo Rodriguez
ABAndres Baraibar
Andres Baraibar
IMIrene Manero-Roig
Irene Manero-Roig
JLjon luzuriaga
jon luzuriaga
JSJone Salvador-Moya
Jone Salvador-Moya
JPJose R. Pineda
Jose R. Pineda
Background: Human dental pulp stem cells (hDPSCs) constitute a promising alternative for central nervous system (CNS) cell therapy. Unlike other human stem cells, hDPSCs can be differentiated, without genetic modification, to neural cells that secrete neuroprotective factors. However, a better understanding of their real capacity to give rise to functional neurons and integrate into synaptic networks is still needed. For that, ex vivo differentiation protocols must be refined, especially to avoid the use of fetal animal serum. Methods: In this study, we sought to improve existing differentiation protocols for obtaining functional neuron-like cells from hDPSCs. We compared the effects of the absence or presence of fetal serum during the initial expansion phase as a step prior to switching cultures to neurodifferentiation media. We improved hDPSC neurodifferentiation by adding retinoic acid (RA) and potassium chloride (KCl) pulses for 21 or 60 days and characterized the results by immunofluorescence, digital morphometric analysis, RT-qPCR and electrophysiology. Results: We found that neural markers like Nestin, GFAP, S100β and p75 NTR were expressed differently in neurodifferentiated hDPSC cultures depending on the presence or absence of serum during the initial cell expansion phase. In addition, hDPSCs previously grown as spheroids in serum-free medium exhibited in vitro expression of neuronal markers such as doublecortin (DCX), neuronal nuclear antigen (NeuN), Ankyrin-G and MAP2 after neurodifferentiation. Presynaptic vGLUT2, Synapsin-I, and excitatory glutamatergic and inhibitory GABAergic postsynaptic scaffold proteins and receptor subunits were also present in these neurodifferentiated hDPSCs. Treatment with KCl and RA increased the amount of both voltage-gated Na + and K + channel subunits in neurodifferentiated hDPSCs at the transcript level. Consistently, these cells displayed voltage-dependent K + and TTX-sensitive Na + currents as well as spontaneous electrophysiological activity and repetitive neuronal action potentials with a full baseline potential recovery. Conclusion: Our study demonstrates, for the first time, that hDPSCs can be differentiated to neuronal-like cells that display functional excitability and thus evidence the potential of these easily accessible human stem cells for nerve tissue engineering. Our results highlight the importance of choosing an appropriate culture protocol to successfully neurodifferentiate hDPSCs.

22 June 2026 in bioRxiv
Verified
Preprint
Open access
BRBeatriz Pardo Rodriguez
Beatriz Pardo Rodriguez
IMIrene Manero-Roig
Irene Manero-Roig
JSJone Salvador-Moya
Jone Salvador-Moya
RBRuth Basanta-Torres
Ruth Basanta-Torres
DMDaniel Martín-Aragón
Daniel Martín-Aragón
JPJose R. Pineda
Jose R. Pineda
Stem cell therapy represents a promising strategy for the replacement and functional restoration of damaged neural tissue in neurodegenerative conditions. Human dental pulp stem cells (hDPSCs) have emerged as potential candidates for neuroregeneration due to their ease of isolation, neural crest origin, neurotrophic and anti-inflammatory capacity, and demonstrated ability to differentiate in vitro into neuronal-like cells exhibiting electrophysiological activity. Although the immunomodulatory and neuroprotective properties of hDPSCs have been reported in multiple models of brain disease, their capacity to functionally integrate into host neuronal circuits remain poorly understood. In this study, we have grafted green fluorescent protein (GFP)-transduced, neural preconditioned hDPSCs into the CA1 region of the hippocampus of C57BL/6J mice. One month after transplantation, GFP + -hDPSCs survived in the brains of non-immunosuppressed mice and remained localized within the grafted area. Notably, the transplanted cells underwent in situ differentiation and exhibited a neuroblast-like phenotype, characterized by positive doublecortin expression and immature neuronal-like electrophysiological properties, like high membrane input resistance, low capacitance, and the ability to generate single action potentials after stimulation. Together, these findings provide the first evidence that hDPSCs can survive and integrate into the hippocampal network of the mouse brain at one-month post graft, supporting their potential use for future therapeutic applications in acute brain lesions and neurodegenerative disorders.